AAV Vector Electroporation for Higher Virus Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing adeno-associated virus (AAV) vectors face challenges in scalability and productivity, particularly for the treatment of systemic diseases, due to issues with chemical reagents like polyethyleneimine and the complexity of controlling plasmid and cell stirring, leading to low virus production efficiency and high costs.
Innovation Solution
A virus production method involving electroporation with specific conditions defined by the CNET product formula, including nucleic acid concentration, electric field strength, and pulse duration, which enhances virus production efficiency and capsid rate, especially using flow electroporation and suspension cells like HEK293, without the need for transfection reagents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If polyethyleneimine is used to neutralize plasmid DNA charge and introduce it into cells via endocytosis, then gene introduction can be achieved, but the process becomes complex and virus production efficiency decreases
Solution Approach 1:
The invention extracts and removes polyethyleneimine from the transfection process, replacing chemical reagent-based endocytosis with direct electroporation. This eliminates the complexity of controlling plasmid-polymer complex formation and stirring, while significantly improving virus production efficiency through direct physical introduction of nucleic acid into cells
Solution Approach 2:
The invention replaces the chemical mechanism (polyethyleneimine-mediated endocytosis) with a physical mechanism (electroporation). By applying electric fields to create temporary pores in cell membranes, the method directly introduces nucleic acid without chemical reagents, simplifying the process and improving productivity
2Productivity
If plasmid and cells are stirred for a long time to facilitate gene introduction, then introduction efficiency improves, but the process complexity and time requirements increase
Solution Approach 1:
The invention uses periodic electric pulses instead of continuous stirring. The electroporation process applies short, intense electric pulses that create temporary pores in cell membranes, allowing rapid nucleic acid uptake without prolonged mechanical stirring. This periodic action achieves high introduction efficiency while dramatically reducing process time
Solution Approach 2:
The invention skips the lengthy stirring process required for chemical transfection by using electroporation. The electric field rapidly drives nucleic acid into cells through membrane pores within seconds, bypassing the need for prolonged mixing and incubation periods
3Productivity
If conventional electroporation methods are used without specific CNET product optimization, then virus production can be achieved, but the amount of virus production is insufficient for systemic disease treatment
Solution Approach 1:
The invention optimizes electroporation parameters by controlling the CNET product (concentration × number of pulses × electric field strength × pulse duration). By adjusting these parameters to achieve a specific CNET product value, the method maximizes virus production yield, producing sufficient quantities for systemic disease treatment while maintaining high-quality viral vectors
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly improves virus production capacity, increasing the full capsid rate and reducing production costs, making it suitable for large-scale production of AAV vectors for systemic disease treatments.
Implementation Method 1
electroporation, which makes use of cell membrane perforation by electric field application and the principle of electrophoresis
Implementation Method 2
the principle of electrophoresis
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
An object of the present invention is to provide a virus production method capable of improving an amount of virus production. According to the present invention, there is provided a virus production method including a nucleic acid introduction step of introducing a nucleic acid into cells via electroporation to obtain cells into which the nucleic acid has been introduced; and a culture step of culturing the cells into which the nucleic acid has been introduced, in which a CNET product defined in the present specification in the electroporation is 1 × 104 or more and 1 × 107 or less.